Delivery Order SPE2DB22D3011-SPE2DB23FQ1XC
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565597402 - Dobutamine 1,000 mg/250 ml D5W 250 ml. The contract is a firm fixed-price delivery order with a ceiling value of $2,644.05 and an ultimate completion date of August 28, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4565781537 - DOBUTAMINE 500 MG/250 ML D5W 250ML, a critical pharmaceutical product. The contract has a firm fixed price of $1,239.64 and a completion date of September 13, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order under its Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,570.08, is for the delivery of DOBUTAMINE 500 MG/250 ML D5W 250ML, a medical product. The contract is a firm fixed-price, delivery order type with an ultimate completion date of March 28, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,174.18 on August 13, 2025, for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2024, for the supply of Dobutamine 500 mg/250 mL in D5W solution, with a contract value of $1,239.62 and ultimate completion date of November 5, 2024. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dobutamine 500 mg/250 mL in 5% dextrose solution with a ceiling value of $1,748.21. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- This is a $1,244.93 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the supply of 4564320534 DOBUTAMINE 500 MG/250 ML D5W 250ML, a pharmaceutical product used in medical treatment. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which serves as the primary vehicle for the company to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DOBUTAMINE 500 MG/250 ML D5W 250ML medical supplies, with a firm fixed price of $1,249.43 and a completion date of June 13, 2025. This contract is not set aside for any specific program or business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,282.48 to AmerisourceBergen Drug Corp for Dobutamine 500 mg/250 mL in D5W solution (250 mL). This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded on July 14, 2025, with an ultimate completion date of July 15, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office headquarters. This...
- Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to supply DOBUTAMINE 500 MG/250 ML D5W 250ML pharmaceuticals. The award has a potential value of $1,029.02 and a completion date of February 28, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA,...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB23FQ1XCDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp (Amerisourcebergen), a major pharmaceutical distributor, for the supply of Dobutamine, a medication used in the treatment of certain cardiac conditions. The delivery order, valued at $1,013.55, has a firm fixed price and an ultimate completion date of July 6, 2023. Amerisourcebergen, through its Corporate Office division, will provide the 250 mg/250 mL Dobutamine in Dextrose 5% solution to support the medical needs of government healthcare facilities and programs. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the company to efficiently supply a wide range of pharmaceutical and medical supplies to the U.S. federal government. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/5/23 |